Percutaneous epicardial ventricular tachycardia ablation after noncoronary cardiac surgery or pericarditis

Cory M Tschabrunn1, Haris M Haqqani, Joshua M Cooper

  • 1Cardiac Electrophysiology Program, Cardiovascular Medicine Division, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Heart Rhythm
|October 13, 2012
PubMed

Insights

Percutaneous pericardial access for ventricular tachycardia (VT) ablation is feasible in patients with prior cardiac surgery or pericarditis. Dividing adhesions allows epicardial mapping and ablation, with good long-term outcomes in half of patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Surgery

Background:

  • Epicardial access is crucial for ventricular tachycardia (VT) ablation in patients with prior noncoronary cardiac surgery or pericarditis.
  • Pericardial adhesions in these patients present significant challenges to percutaneous pericardial access.

Purpose of the Study:

  • To evaluate the success and safety of percutaneous pericardial access for VT ablation.
  • To assess the feasibility of mapping and ablating epicardial VT targets in challenging patient populations.

Main Methods:

  • A study of 10 consecutive patients with prior noncoronary cardiac surgery or pericarditis requiring epicardial access for VT ablation.
  • Experienced operators used blunt dissection with a deflected ablation catheter to divide dense pericardial adhesions, enabling epicardial mapping.

Main Results:

  • Percutaneous pericardial access was achieved in all patients, with adhesions successfully divided in 19-125 minutes.
  • Epicardial mapping was sufficient in 90% of patients, and targeted VTs were rendered noninducible in 80%.
  • Long-term follow-up showed 50% of patients remained VT-free, with no major complications reported besides initial puncture bleeding in one patient.

Conclusions:

  • Percutaneous pericardial access for epicardial VT ablation is generally obtainable in patients with prior cardiac surgery or pericarditis.
  • Dense adhesions frequently encountered require disruption for adequate epicardial mapping and ablation.
  • This approach facilitates excellent long-term outcomes in approximately half of the patients without major complications.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...